Needle-based Confocal Laser Endomicroscopy in CT-guided Percutaneous Procedures

Sponsor
Mauna Kea Technologies (Industry)
Overall Status
Completed
CT.gov ID
NCT02288104
Collaborator
(none)
16
1
1
26.5
0.6

Study Details

Study Description

Brief Summary

This study is a prospective study in order to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: Kidneys and liver.

This innovative study will involve the use of probe-based confocal laser endomicroscopy. The proposed study is a feasibility study.

Condition or Disease Intervention/Treatment Phase
  • Device: needle based confocal endomicroscopy
N/A

Detailed Description

Interventional radiology is a medical sub-specialty of radiology which utilizes minimally-invasive image-guided procedures to diagnose and treat diseases in nearly every organ. The concept behind interventional radiology is to diagnose and treat patients using less invasive techniques currently available in order to minimize risk to the patient and improve health outcomes.

For many years, surgery was the only treatment available for many conditions. Today, interventional radiology treatments are frst-line care for a wide variety of conditions. Patients should be offered the least invasive option frst. It is important to get a second opinion and know all of your treatment options before consenting to any procedure or surgery. Interventional radiologists are specialists in minimally invasive treatments, have a unique breadth of training and provide consults to every type of specialist.

Surgical removal of liver tumors offers the best chance for a cure. Unfortunately, liver tumors are often inoperable because the tumor may be too large, or has grown into major blood vessels or other vital structures. Sometimes, many small tumors are spread throughout the liver, making surgery too risky or impractical. Surgical removal is not possible for more than two-thirds of primary liver cancer patients and 90 percent of patients with secondary liver cancer.

The objectives of this study are to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: liver and kidneys.

The Primary objective is:

To study and demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure in two main indications: liver and kidney.

The Secondary objectives are:
  1. Assess the safety of the use of Endomicroscopic imaging during interventional radiology procedure in two main indications: liver and kidney.

  2. Assess the quality of biopsies performed with the help of Cellvizio.

  3. Build a database of images as an atlas and define image interpretation criteria in collaboration with pathologists.

Evaluate whether and how Cellvizio can improve guidance for biopsies or ablations: for instance, in the critical structures such as nerves or vessels in the vicinity of the cryoablation area, is it possible to visualize ice crystals and therefore decide to stop the cryoablation at the right time/location?

For both applications, technical feedback from the physicians is expected on how they think the combined use of the devices could change the care path. E.g. a certain step in the workflow might become obsolete or the workflow could lead to fewer patient visits.

For the safety of this protocol, the use of endomicroscopy will not change in any way the patient management and standard procedure, including the diagnosis nor treatment decisions. All the adverse events / serious adverse events will be noted during the procedure and one week after the procedure.

Study Design

Study Type:
Interventional
Actual Enrollment :
16 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Needle-based Confocal Laser Endomicroscopy in CT-guided Procedures in Interventional Radiology With Applications in Liver and Kidneys: a Feasibility Study
Study Start Date :
Jan 1, 2015
Actual Primary Completion Date :
Mar 17, 2017
Actual Study Completion Date :
Mar 17, 2017

Arms and Interventions

Arm Intervention/Treatment
Other: needle based confocal endomicroscopy

The patient, scheduled for a standard liver or kidney percutaneous biopsy or ablation will undergo a needle-based confocal laser endomicroscopy procedure during the procedure. The objectives of this study are to demonstrate the technical feasibility and safety of doing endomicroscopic imaging during interventional radiology procedure and determine whether it is technically feasible to obtain images from Cellvizio during an interventional radiology procedure.

Device: needle based confocal endomicroscopy
real time imaging of living tissue at microscopic scale, through a needle.

Outcome Measures

Primary Outcome Measures

  1. Diagnostic accuracy (sensitivity specificity) of endomicroscopy as compared to histopathology [up to 2 weeks]

    Assessment of the accuracy of Cellvizio confocal mini probe imaging guided by fluoroscopy at the tumor boundary compared with traditional histopathology from physical biopsies

Secondary Outcome Measures

  1. Measure adverse events frequency in the use of mini probes on the tumor [Up to 1 week]

    Assessment of the safety of inserting Cellvizio confocal miniprobe in the tumor (nor increase in bleeding or tumor cell dissemination) through the frequency, type and severity of adverse events

  2. Classification of endomicroscopy images from benign and malignant conditions [Up to 6 months]

    A first creation of an atlas of endomicroscopic images obtained in interventional radiology with corresponding correlation with traditional pathology images

  3. Percentage of biopsies guided by nCLE (needle-based Confocal Laser Endomicroscopy) which provide a definitive diagnosis as a measure of efficiency of endomicroscopy-targeted biopsies compared to traditional needle biopsies [Up to 5 months]

    Yield of nCLE (needle-based confocal laser endomicroscopy)-targeted Fluoroscopy-guided biopsies to assess improvements compared to standard of care from guidance function of the device combination

  4. Number of patients for whom endomicroscopy could have affected the clinical workflow [Up to 5 months]

    Evaluation of the potential impact of the endomicroscopic information used in conjunction with the Siemens SOMATOM Definition system in clinical decision-making for each patient

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients scheduled to have an interventional radiology procedure for needle-biopsy or radiofrequency ablation purposes in liver or Kidney.

  • Only subjects who have provided written informed consent for the study can be included in the study.

Exclusion Criteria:
  • Patients have a known allergy to fluorescein

  • Patient is Pregnant or breast-feeding

  • Patient under judiciary control

  • Patient under the tutelage of a guardian

  • Patient unable to sign the information consent form (in case of an emergency situation or difficulty in understanding the information)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Nouvel Hôpital Civil Strasbourg France 67091

Sponsors and Collaborators

  • Mauna Kea Technologies

Investigators

  • Principal Investigator: Afshin Gangi, NHC, Strasbourg, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mauna Kea Technologies
ClinicalTrials.gov Identifier:
NCT02288104
Other Study ID Numbers:
  • MKT-IR-NHC-2014
First Posted:
Nov 11, 2014
Last Update Posted:
Aug 29, 2017
Last Verified:
Aug 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Keywords provided by Mauna Kea Technologies

Study Results

No Results Posted as of Aug 29, 2017